FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anne Novak

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Physiology

Procedures

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Co-author Network

Publications

TOP 3
Zhi-Zhang Yang; Nicole R Yates; Steven C Ziesmer; Deanna M Grote; Lucy S Hodge; Anne J Novak; Frank J Secreto; Thomas E Witzig; Bing Xiu; Stephen M Ansell
Soluble and Membrane-Bound TGF-β-Mediated Regulation of Intratumoral T Cell Differentiation and Function in B-Cell Non-Hodgkin Lymphoma.
Bridget Charbonneau; Zachary S Fredericksen; Thomas M Habermann; Brian K Link; William R Macon; Matthew J Maurer; Stephen M Ansell; James R Cerhan; Susan L Slager; Thomas E Witzig; Steven C Ziesmer; Anne J Novak
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study.
Stephen M Ansell; Esteban Braggio; James R Cerhan; Ahmet Dogan; Martin J S Dyer; Rafael Fonseca; Mamta Gupta; Mark Law; Michelle Manske; Ellen McPhail; Tammy Price-Troska; Frank Secreto; Thomas E Witzig; Steven C Ziesmer; Takashi Akasaka; Anne J Novak
t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anne Novak (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Zhi-Zhang Yang; Nicole R Yates; Steven C Ziesmer; Deanna M Grote; Lucy S Hodge; Anne J Novak; Frank J Secreto; Thomas E Witzig; Bing Xiu; Stephen M Ansell
Soluble and Membrane-Bound TGF-β-Mediated Regulation of Intratumoral T Cell Differentiation and Function in B-Cell Non-Hodgkin Lymphoma.
PloS one 2013;8(3):e59456.
2012: Bridget Charbonneau; Zachary S Fredericksen; Thomas M Habermann; Brian K Link; William R Macon; Matthew J Maurer; Stephen M Ansell; James R Cerhan; Susan L Slager; Thomas E Witzig; Steven C Ziesmer; Anne J Novak
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study.
Cytokine 2012;60(3):882-9.
2012: Stephen M Ansell; Esteban Braggio; James R Cerhan; Ahmet Dogan; Martin J S Dyer; Rafael Fonseca; Mamta Gupta; Mark Law; Michelle Manske; Ellen McPhail; Tammy Price-Troska; Frank Secreto; Thomas E Witzig; Steven C Ziesmer; Takashi Akasaka; Anne J Novak
t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.
Blood 2012;120(19):3949-57.
2012: Lucy S Hodge; Anne J Novak; Frank J Secreto; Zhi-Zhang Yang; Steven C Ziesmer; Morie A Gertz; Stephen M Ansell
IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia.
Blood 2012;120(18):3774-82.
2012: James R Cerhan; Julie M Cunningham; Ahmet Dogan; Zachary S Fredericksen; Thomas M Habermann; Neil E Kay; Mark Liebow; Anne J Novak; Stephen M Ansell; Yan W Asmann; Alice H Wang; Thomas E Witzig; Susan L Slager
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(10):1799-806.
2012: Bridget Charbonneau; Ahmet Dogan; Zachary S Fredericksen; Thomas M Habermann; Brian K Link; Matthew J Maurer; Anne J Novak; Susan L Slager; Alice H Wang; George J Weiner; Thomas E Witzig; Clive S Zent; Stephen M Ansell; James R Cerhan
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.
American journal of hematology 2012;87(9):880-5.
2012: Stephen M Ansell; James R Cerhan; Ahmet Dogan; Thomas M Habermann; Brian K Link; William R Macon; Matthew J Maurer; Susan L Slager; Thomas E Witzig; Steven C Ziesmer; Anne J Novak
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.
American journal of hematology 2012;87(9):865-9.
2012: Zhi-Zhang Yang; Steven C Ziesmer; Deanna M Grote; Mitsuomi Hirashima; Toshiro Niki; Anne J Novak; Thomas E Witzig; Stephen M Ansell
IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma.
The Journal of clinical investigation 2012;122(4):1271-82.
2011: Sherine F Elsawa; Martin E Fernandez Zapico; Deanna M Grote; Lucy S Hodge; Anne J Novak; Thomas E Witzig; Steven C Ziesmer; Luciana L Almada; Stephen M Ansell
Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity.
Blood 2011;118(20):5540-9.
2011: Marek Mraz; Anne J Novak; Stephen M Ansell; Amy K Church; Diane F Jelinek; Neil E Kay; Sarka Pospisilova; Thomas E Witzig; Xiaosheng Wu; Clive S Zent; Grzegorz S Nowakowski
Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance.
British journal of haematology 2011;155(1):53-64.
2011: Zhi-Zhang Yang; Steven C Ziesmer; Deanna M Grote; Michelle K Manske; Anne J Novak; Thomas E Witzig; Stephen M Ansell
Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.
Blood 2011;118(10):2809-20.
2011: Sherine F Elsawa; Luciana L Almada; Stephen M Ansell; Anne J Novak; Thomas E Witzig; Steven C Ziesmer; Martin E Fernandez Zapico
GLI2 transcription factor mediates cytokine cross-talk in the tumor microenvironment.
The Journal of biological chemistry 2011;286(24):21524-34.
2011: Lucy S Hodge; Anne J Novak; Deanna M Grote; Esteban Braggio; Rhett P Ketterling; Michelle K Manske; Tammy L Price-Troska; Steven C Ziesmer; Rafael Fonseca; Thomas E Witzig; William Morice; Morie A Gertz; Stephen M Ansell
Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.
Blood 2011;117(19):e190-7.
2010: Joanne M Hildebrand; Zhenghua Luo; Michelle K Manske; Tammy Price-Troska; Steven C Ziesmer; Wai Lin; Bruce S Hostager; Susan L Slager; Thomas E Witzig; Stephen M Ansell; James R Cerhan; Gail A Bishop; Anne J Novak
A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling.
The Journal of experimental medicine 2010;207(12):2569-79.
2009: Ryan A Wilcox; David A Wada; Steven C Ziesmer; Sherine F Elsawa; Nneka I Comfere; Allan B Dietz; Anne J Novak; Thomas E Witzig; Andrew L Feldman; Mark R Pittelkow; Stephen M Ansell
Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells.
Blood 2009;114(14):2936-44.
2009: Mamta Gupta; Stephen M Ansell; Anne J Novak; Shaji Kumar; Scott H Kaufmann; Thomas E Witzig
Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2.
Blood 2009;114(14):2926-35.
2009: Ryan A Wilcox; Andrew L Feldman; David A Wada; Zhi-Zhang Yang; Nneka I Comfere; Haidong Dong; Eugene D Kwon; Anne J Novak; Svetomir N Markovic; Mark R Pittelkow; Thomas E Witzig; Stephen M Ansell
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.
Blood 2009;114(10):2149-58.
2009: Zhi-Zhang Yang; Anne J Novak; Steven C Ziesmer; Thomas E Witzig; Stephen M Ansell
Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma.
Cancer research 2009;69(13):5522-30.
2009: James Cerhan; Anne J Novak; Zachary S Fredericksen; Alice H Wang; Mark Liebow; Timothy G Call; Ahmet Dogan; Thomas E Witzig; Stephen M Ansell; Thomas M Habermann; Neil E Kay; Susan L Slager
Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
British journal of haematology 2009;145(5):614-23.
2009: Mamta Gupta; Stacey R Dillon; Steven C Ziesmer; Andrew L Feldman; Thomas E Witzig; Stephen M Ansell; James Cerhan; Anne J Novak
A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation.
Blood 2009;113(21):5206-16.
2009: Anne J Novak; Susan L Slager; Zachary S Fredericksen; Alice H Wang; Michelle M Manske; Steven C Ziesmer; Mark Liebow; William R Macon; Stacey R Dillon; Thomas E Witzig; James Cerhan; Stephen M Ansell
Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma.
Cancer research 2009;69(10):4217-24.
2009: Stephen M Ansell; Anne J Novak; Steven C Ziesmer; Tammy Price-Troska; Betsy LaPlant; Stacey R Dillon; Thomas E Witzig
Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphoma.
American journal of hematology 2009;84(2):71-3.
2008: Sherine F Elsawa; Anne J Novak; Deanna M Grote; Marina Konopleva; Michael Andreeff; Thomas E Witzig; Stephen M Ansell
CDDO-imidazolide mediated inhibition of malignant cell growth in Waldenström macroglobulinemia.
Leukemia research 2008;32(12):1895-902.
2008: A L Feldman; D X Sun; Mark E Law; Anne J Novak; Ayoma D Attygalle; Erik C Thorland; S R Fink; J A Vrana; B L Caron; William Morice; Ellen D Remstein; Karen L Grogg; Paul J Kurtin; William R Macon; Ahmet Dogan
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.
Leukemia 2008;22(6):1139-43.
2008: Stephen M Ansell; Thomas E Witzig; David J Inwards; Luis F Porrata; Arnaud Ythier; Lee Ferrande; Ivan Nestorov; Todd Devries; Stacey R Dillon; Diana Hausman; Anne J Novak
Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(4):1105-10.
2007: Zhi-Zhang Yang; Anne J Novak; Steven C Ziesmer; Thomas E Witzig; Stephen M Ansell
CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells.
Blood 2007;110(7):2537-44.
2006: Stephen M Ansell; Susan M Geyer; Matthew J Maurer; Paul J Kurtin; Ivana N M Micallef; Philip J Stella; Paul Etzell; Anne J Novak; Charles Erlichman; Thomas E Witzig
Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):6056-63.
2006: Zhi-Zhang Yang; Anne J Novak; Steven C Ziesmer; Thomas E Witzig; Stephen M Ansell
Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.
Cancer research 2006;66(20):10145-52.
2006: Zhi-Zhang Yang; Anne J Novak; Mary J Stenson; Thomas E Witzig; Stephen M Ansell
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.
Blood 2006;107(9):3639-46.
2006: Sherine F Elsawa; Anne J Novak; Deanna M Grote; Steven C Ziesmer; Thomas E Witzig; Robert A Kyle; Stacey R Dillon; Brandon Harder; Jane A Gross; Stephen M Ansell
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.
Blood 2006;107(7):2882-8.
2006: Stacey R Dillon; Jane A Gross; Stephen M Ansell; Anne J Novak
An APRIL to remember: novel TNF ligands as therapeutic targets.
Nature reviews. Drug discovery 2006;5(3):235-46.
2006: Anne J Novak; Deanna M Grote; Steven C Ziesmer; Michael P Kline; Michelle K Manske; Susan Slager; Thomas E Witzig; Tait D Shanafelt; Timothy G Call; Neil E Kay; Diane F Jelinek; James Cerhan; Jane A Gross; Brandon Harder; Stacey R Dillon; Stephen M Ansell
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):983-7.
2005: Irene M Ghobrial; Daniel J McCormick; Scott H Kaufmann; Alexey A Leontovich; David Loegering; Nga T Dai; Kelly L Krajnik; Mary J Stenson; Mona F Melhem; Anne J Novak; Stephen M Ansell; Thomas E Witzig
Proteomic analysis of mantle-cell lymphoma by protein microarray.
Blood 2005;105(9):3722-30.
2004: Anne J Novak; Deanna M Grote; Mary J Stenson; Steven C Ziesmer; Thomas E Witzig; Thomas M Habermann; Brandon Harder; Kay M Ristow; Richard J Bram; Diane F Jelinek; Jane A Gross; Stephen M Ansell
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.
Blood 2004;104(8):2247-53.
2004: Irene M Ghobrial; Nancy D Bone; Mary J Stenson; Anne J Novak; Karen E Hedin; Neil E Kay; Stephen M Ansell
Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Mayo Clinic proceedings. Mayo Clinic 2004;79(3):318-25.
2004: Stephen M Ansell; Bonnie K Arendt; Deanna M Grote; Diane F Jelinek; Anne J Novak; L E Wellik; Ellen D Remstein; C F Bennett; A Fielding
Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma.
Leukemia 2004;18(3):616-23.
2004: Anne J Novak; Jaime R Darce; Bonnie K Arendt; Brandon Harder; Kathy Henderson; Wayne Kindsvogel; Jane A Gross; Philip R Greipp; Diane F Jelinek
Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.
Blood 2004;103(2):689-94.
2002: Anne J Novak; Richard J Bram; Neil E Kay; Diane F Jelinek
Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival.
Blood 2002;100(8):2973-9.